These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Determining the optimal dose of tenecteplase before endovascular therapy for ischemic stroke (EXTEND-IA TNK Part 2): A multicenter, randomized, controlled study. Campbell BC; Mitchell PJ; Churilov L; Yassi N; Kleinig TJ; Yan B; Thijs V; Desmond PM; Parsons MW; Donnan GA; Davis SM Int J Stroke; 2020 Jul; 15(5):567-572. PubMed ID: 31564231 [TBL] [Abstract][Full Text] [Related]
24. Major Bleeding Postadministration of Tenecteplase Versus Alteplase in Acute Ischemic Stroke. Walton MN; Hamilton LA; Salyer S; Wiseman BF; Forster AM; Rowe AS Ann Pharmacother; 2023 May; 57(5):535-543. PubMed ID: 36004394 [TBL] [Abstract][Full Text] [Related]
25. Tenecteplase versus alteplase in acute ischemic stroke: systematic review and meta-analysis. Thelengana A; Radhakrishnan DM; Prasad M; Kumar A; Prasad K Acta Neurol Belg; 2019 Sep; 119(3):359-367. PubMed ID: 29728903 [TBL] [Abstract][Full Text] [Related]
26. Comparison of thrombolytic agents in treatment of patients with acute ischemic stroke; findings from a single centre follow up study in real-life settings. George M; Baby N; Paul R; Zabeer M; Thomas C J Clin Neurosci; 2021 Sep; 91():299-305. PubMed ID: 34373043 [TBL] [Abstract][Full Text] [Related]
27. Evidence that Tenecteplase Is Noninferior to Alteplase for Acute Ischemic Stroke: Meta-Analysis of 5 Randomized Trials. Burgos AM; Saver JL Stroke; 2019 Aug; 50(8):2156-2162. PubMed ID: 31318627 [TBL] [Abstract][Full Text] [Related]
28. Reduced Severity of Tissue Injury Within the Infarct May Partially Mediate the Benefit of Reperfusion in Ischemic Stroke. Ng FC; Churilov L; Yassi N; Kleinig TJ; Thijs V; Wu TY; Shah DG; Dewey HM; Sharma G; Desmond PM; Yan B; Parsons MW; Donnan GA; Davis SM; Mitchell PJ; Leigh R; Campbell BCV; Stroke; 2022 Jun; 53(6):1915-1923. PubMed ID: 35135319 [TBL] [Abstract][Full Text] [Related]
29. Conversion From Intravenous Alteplase to Tenecteplase for Treatment of Acute Ischemic Stroke Across a Large Community Hospital Health System. Dittmar E; Wolfel T; Menendez L; Pozo J; Ramirez M; Belnap SC; De Los Rios La Rosa F Ann Pharmacother; 2023 Oct; 57(10):1147-1153. PubMed ID: 36688289 [TBL] [Abstract][Full Text] [Related]
30. Tenecteplase vs. alteplase for the treatment of patients with acute ischemic stroke: a systematic review and meta-analysis. Ma P; Zhang Y; Chang L; Li X; Diao Y; Chang H; Hui L J Neurol; 2022 Oct; 269(10):5262-5271. PubMed ID: 35776193 [TBL] [Abstract][Full Text] [Related]
31. Tenecteplase versus alteplase in stroke thrombolysis: An individual patient data meta-analysis of randomized controlled trials. Huang X; MacIsaac R; Thompson JL; Levin B; Buchsbaum R; Haley EC; Levi C; Campbell B; Bladin C; Parsons M; Muir KW Int J Stroke; 2016 Jul; 11(5):534-43. PubMed ID: 27048693 [TBL] [Abstract][Full Text] [Related]
32. Tenecteplase Treatment and Thrombus Characteristics Associated With Early Reperfusion: An EXTEND-IA TNK Trials Analysis. Yogendrakumar V; Churilov L; Guha P; Beharry J; Mitchell PJ; Kleinig TJ; Yassi N; Thijs V; Wu TY; Brown H; Dewey HM; Wijeratne T; Yan B; Sharma G; Desmond PM; Parsons MW; Donnan GA; Davis SM; Campbell BCV; Stroke; 2023 Mar; 54(3):706-714. PubMed ID: 36727510 [TBL] [Abstract][Full Text] [Related]
33. Acute ischemic stroke thrombolysis with tenecteplase: An institutional experience from South India. Owais M; Panwar A; Valupadas C; Veeramalla M Ann Afr Med; 2018; 17(2):90-93. PubMed ID: 29536964 [TBL] [Abstract][Full Text] [Related]
34. Prospective Observational Cohort Study of Tenecteplase Versus Alteplase in Routine Clinical Practice. Warach SJ; Dula AN; Milling TJ; Miller S; Allen L; Zuck ND; Miller C; Jesser CA; Misra LR; Miley JT; Mawla M; Ding MC; Bertelson JA; Tsui AY; Jefferson JR; Davison HM; Shah DN; Ellington KT; Padrick MM; Nova AS; Krishna VR; Davis LA; Paydarfar D Stroke; 2022 Dec; 53(12):3583-3593. PubMed ID: 36148657 [TBL] [Abstract][Full Text] [Related]
35. Intravenous Thrombolysis With Tenecteplase in Patients With Large Vessel Occlusions: Systematic Review and Meta-Analysis. Katsanos AH; Safouris A; Sarraj A; Magoufis G; Leker RR; Khatri P; Cordonnier C; Leys D; Shoamanesh A; Ahmed N; Alexandrov AV; Tsivgoulis G Stroke; 2021 Jan; 52(1):308-312. PubMed ID: 33272127 [TBL] [Abstract][Full Text] [Related]
36. Safety and Efficacy of Tenecteplase in Older Patients With Large Vessel Occlusion: A Pooled Analysis of the EXTEND-IA TNK Trials. Yogendrakumar V; Churilov L; Mitchell PJ; Kleinig TJ; Yassi N; Thijs V; Wu TY; Shah DG; Ng FC; Dewey HM; Wijeratne T; Yan B; Desmond PM; Parsons MW; Donnan GA; Davis SM; Campbell BCV; Neurology; 2022 Mar; 98(12):e1292-e1301. PubMed ID: 35017305 [TBL] [Abstract][Full Text] [Related]
37. Tenecteplase for the treatment of acute ischemic stroke: A review of completed and ongoing randomized controlled trials. Coutts SB; Berge E; Campbell BC; Muir KW; Parsons MW Int J Stroke; 2018 Dec; 13(9):885-892. PubMed ID: 30035698 [TBL] [Abstract][Full Text] [Related]
38. The Impact of CT Perfusion Threshold on Predicted Viable and Nonviable Tissue Volumes in Acute Ischemic Stroke. Huang X; Kalladka D; Cheripelli BK; Moreton FC; Muir KW J Neuroimaging; 2017 Nov; 27(6):602-606. PubMed ID: 28414895 [TBL] [Abstract][Full Text] [Related]
39. Off-Label Use of Tenecteplase for the Treatment of Acute Ischemic Stroke: A Systematic Review and Meta-analysis. Katsanos AH; Psychogios K; Turc G; Sacco S; de Sousa DA; De Marchis GM; Palaiodimou L; Filippou DK; Ahmed N; Sarraj A; Menon BK; Tsivgoulis G JAMA Netw Open; 2022 Mar; 5(3):e224506. PubMed ID: 35357458 [TBL] [Abstract][Full Text] [Related]